Intracranial and fatal bleeding according to indication for long‐term oral anticoagulant therapy
Authors:
- 1 October 2010
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 8 (10) , 2201-2207
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillationEP Europace, 2007
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patientsJournal of Thrombosis and Haemostasis, 2005
- Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialThe Lancet, 2003
- Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation∗∗The investigators and institutions participating in the study are listed in the Appendix.The American Journal of Cardiology, 1998
- A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial originAnnals of Neurology, 1997
- Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: A randomized trial in patients with mechanical prosthetic heart valvesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor strokeThe Lancet, 1993
- Canadian atrial fibrillation anticoaguiation (CAFA) studyJACC, 1991
- Trial of Different Intensities of Anticoagulation in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1990